OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$8.72B
1-Year Return
19.29%
This Quarter Return
+12.94%
1 Year Return
+19.29%
3 Year Return
+71.82%
5 Year Return
+126.54%
10 Year Return
+242.9%
AUM
$4.45B
AUM Growth
+$416M
(+10%)
Cap. Flow
-$63.5M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
1,684
New
54
Increased
786
Reduced
691
Closed
80
Top Buys
| 1 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$21.9M |
| 2 |
Lumen
LUMN
|
$13.6M |
| 3 |
First Trust Managed Municipal ETF
FMB
|
$11.3M |
| 4 |
Vodafone
VOD
|
$9.49M |
| 5 |
CVS Health
CVS
|
$7.42M |
Top Sells
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$40.6M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$37.3M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
$27.3M |
| 4 |
VanEck Intermediate Muni ETF
ITM
|
$14.3M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
$8.14M |
Sector Composition
| 1 | Technology | 15.34% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 12.26% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Discretionary | 8.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Devon Energy
DVN
$22.1B
| $8.98M | 0.2% |
284,549
+94,796
| +50% | +$2.99M |
|
127
Vertex Pharmaceuticals
VRTX
$102B
| $8.98M | 0.2% |
48,807
-3,805
| -7% | -$700K |
|
128
Zimmer Biomet
ZBH
$20.9B
| $8.93M | 0.2% |
72,038
-30,719
| -30% | -$3.81M |
|
129
Cognizant
CTSH
$35.1B
| $8.9M | 0.2% |
122,837
+20,596
| +20% | +$1.49M |
|
130
Equitable Holdings
EQH
$16B
| $8.69M | 0.2% |
431,398
+122,277
| +40% | +$2.46M |
|
|
NBL
131
DELISTED
Noble Energy, Inc.
NBL
| $8.52M | 0.19% |
344,367
+34,769
| +11% | +$860K |
|
132
MetLife
MET
$52.9B
| $8.51M | 0.19% |
199,904
-97,214
| -33% | -$4.14M |
|
133
Ulta Beauty
ULTA
$23.1B
| $8.48M | 0.19% |
24,308
-4,397
| -15% | -$1.53M |
|
|
134
iShares Russell 1000 Value ETF
IWD
$63.5B
| $8.47M | 0.19% |
68,617
-302,245
| -81% | -$37.3M |
|
135
Burlington
BURL
$18.4B
| $8.39M | 0.19% |
53,552
+16,374
| +44% | +$2.57M |
|
136
AstraZeneca
AZN
$253B
| $8.24M | 0.19% |
203,762
-4,714
| -2% | -$191K |
|
137
GSK
GSK
$81.6B
| $8.19M | 0.18% |
156,752
-18,534
| -11% | -$968K |
|
138
Amgen
AMGN
$153B
| $8.18M | 0.18% |
43,036
-755
| -2% | -$143K |
|
|
139
CVS Health
CVS
$93.6B
| $8.08M | 0.18% |
149,829
+137,539
| +1,119% | +$7.42M |
|
|
ABB
140
DELISTED
ABB Ltd.
ABB
| $8.03M | 0.18% |
425,759
+55,731
| +15% | +$1.05M |
|
141
Canadian National Railway
CNI
$60.3B
| $8.03M | 0.18% |
89,766
-12,922
| -13% | -$1.16M |
|
142
Becton Dickinson
BDX
$55.1B
| $7.99M | 0.18% |
32,784
-9,096
| -22% | -$2.22M |
|
143
Analog Devices
ADI
$122B
| $7.92M | 0.18% |
75,260
+2,791
| +4% | +$294K |
|
144
Air Products & Chemicals
APD
$64.5B
| $7.92M | 0.18% |
41,478
-5,973
| -13% | -$1.14M |
|
145
Tapestry
TPR
$21.7B
| $7.91M | 0.18% |
243,395
+13,570
| +6% | +$441K |
|
146
Takeda Pharmaceutical
TAK
$48.6B
| $7.83M | 0.18% |
384,408
+74,247
| +24% | +$1.51M |
|
147
Rollins
ROL
$27.4B
| $7.83M | 0.18% |
282,167
+15,575
| +6% | +$432K |
|
148
Schlumberger
SLB
$53.4B
| $7.68M | 0.17% |
176,261
+5,862
| +3% | +$255K |
|
149
NVIDIA
NVDA
$4.07T
| $7.65M | 0.17% |
1,705,040
+173,360
| +11% | +$778K |
|
150
Baidu
BIDU
$35.1B
| $7.61M | 0.17% |
46,158
-451
| -1% | -$74.3K |
|